Submitted by Anonymous (not verified) on 5 September 2025 - 15:05
Human medicines European public assessment report (EPAR): Nintedanib Viatris, nintedanib, Date of authorisation: 22/08/2025, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Nintedanib Viatris, nintedanib, Date of authorisation: 22/08/2025, Status: Authorised